Exploring the Analgesic and Antidiarrheal Properties of Angelicin Through Cyclooxygenase Inhibition and Μ‐Opioid Receptor Interaction: In Vivo and In Silico Studies
Drug Development Research · 2025
DOI: 10.1002/ddr.70201 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Development Research, 2025. Verfasst von Sourav Bagchi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Gopalganj Science and Technology University, Gopalganj, Dhaka, Bangladesh. Hauptthemen laut MEDLINE: Antidiarrheals, Analgesics, Receptors, Opioid, mu, Diarrhea. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: Deanship of Scientific Research, King Khalid University, the Research Project under grant number (RGP.2/533/44)..
Abstract (Originalsprache)
Angelicin (AGN), an angular furocoumarin, exhibits notable anti‐inflammatory and biological activities. However, its potential for managing pain and diarrhea, and the underlying mechanisms, remain poorly explored. This study aimed to investigate the analgesic and antidiarrheal properties of AGN and elucidate its possible mechanisms of action through in vivo and in silico approaches. Mice received AGN (2.5, 5, and 10 mg/kg, i.p), DFS (25 mg/kg, p.o), LOP (3 mg/kg p.o), and BSS (10 mg/kg, p.o), after 30 min of administration, for an analgesic test; 0.7% acetic acid at 10 mL/kg (i.p) induced writhing, observed latency, and number of writhing. Antidiarrheal activity was assessed by using castor oil (0.5 mL, p.o) induced diarrhea in mice, observing latency and number of diarrhea secretions over 3 h. Additionally, Molecular docking studies were performed to analyze AGN's interactions with cyclooxygenase (COX‐1/2) enzymes and the µ‐opioid receptor (MOR). Drug‐likeness and toxicity profiles were predicted using SwissADME and ProTox‐III. AGN demonstrated significant, dose‐dependent analgesic and antidiarrheal effects. Its combination with standard drugs (DFS, LOP, BSS) showed enhanced efficacy. Molecular docking revealed strong binding affinities of AGN for COX‐1 (−7.4 kcal/mol), COX‐2 (−8.0 kcal/mol), and MOR (−7.1 kcal/mol). Pharmacokinetic predictions indicated good drug‐likeness, and toxicity profiling suggested a favorable safety margin. These results strongly suggest that AGN is a promising dual‐action therapeutic candidate for pain and diarrhea, likely mediated through COX inhibition and MOR interaction. Further studies are warranted to validate these mechanisms and develop optimized AGN‐based formulations for clinical translation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Gopalganj Science and Technology University, Gopalganj, Dhaka, Bangladesh.
- Department of Pharmacy, Pabna University of Science and Technology, Pabna, Rajshahi, Bangladesh.
- Phytochemistry and Biodiversity Research Laboratory, BioLuster Research Center Ltd., Gopalganj, Dhaka, Bangladesh.
- Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha, Asir, Saudi Arabia.
- Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, University of Tabuk, Tabuk, Tabuk, Saudi Arabia.
- Department of Family and Community Medicine, Faculty of Medicine, University of Tabuk, Tabuk, Tabuk, Saudi Arabia.
ORCID-Profile: Mst Muslima Khatun, Md Shimul Bhuia, Mohammed Alfaifi, Faisal H Altemani, Salehin Sheikh
Förderung
- Deanship of Scientific Research, King Khalid University, the Research Project under grant number (RGP.2/533/44).
Zitieren
APA
Bagchi, S., Bishwas, D., Khatun, M. M., Oni, M. I. J., Bhuia, M. S., Alfaifi, M., Altemani, F. H., Altemani, A. H., Sheikh, S., & Islam, M. T. (2025). Exploring the Analgesic and Antidiarrheal Properties of Angelicin Through Cyclooxygenase Inhibition and Μ‐Opioid Receptor Interaction: In Vivo and In Silico Studies. Drug Development Research. https://doi.org/10.1002/ddr.70201
Vancouver
Bagchi S, Bishwas D, Khatun MM, Oni MIJ, Bhuia MS, Alfaifi M, et al. Exploring the Analgesic and Antidiarrheal Properties of Angelicin Through Cyclooxygenase Inhibition and Μ‐Opioid Receptor Interaction: In Vivo and In Silico Studies. Drug Development Research. 2025. doi:10.1002/ddr.70201
BibTeX
@article{Bagchi2025,
author = {Bagchi, Sourav and Bishwas, Dipu and Khatun, Mst Muslima and Oni, Most Israt Jahan and Bhuia, Md Shimul and Alfaifi, Mohammed and Altemani, Faisal H and Altemani, Abdullah H and Sheikh, Salehin and Islam, Muhammad Torequl},
title = {Exploring the Analgesic and Antidiarrheal Properties of Angelicin Through Cyclooxygenase Inhibition and Μ‐Opioid Receptor Interaction: In Vivo and In Silico Studies},
journal = {Drug Development Research},
year = {2025},
doi = {10.1002/ddr.70201}
}
EUVIMED